TelyRx Holdings Inc. is making waves on the TSX with a remarkable 5.60% increase in just one trading day.
TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 5.60% in the latest trading session, closing at CA$2.64. This rise follows some exciting company news and a strong performance in the healthcare sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$66.45M
52W high
$4.25
52W low
$2.00
1W change
+6.38%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 140.0% over the next 12 months.
Consensus
No RatingAvg. Target
C$6.00
+140.0% Upside
Current Price
C$2.50
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
83.1%
Annualized
90-Day Vol
93.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.09
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.36 | C$1.77 โ C$3.14 |
| 60 trading days | C$2.22 | C$1.48 โ C$3.33 |
| 90 trading days | C$2.09 | C$1.27 โ C$3.44 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on TelyRx as it expands its market presence and engages with investors through upcoming events.
TelyRx Holdings Inc. sees a 5.60% increase in stock price.
With a market cap of CA$66.4 million, TelyRx is positioned for growth but faces profitability challenges.
Bull case
The company recently hit a significant milestone by filling over one million prescriptions. Its participation in the Global Technology Virtual Investor Conference is also a promising sign of growth potential and investor interest.
Bear case
Despite the positive movement, TelyRx's negative profit margin and the risks in the healthcare sector could challenge its ability to maintain growth.
Recent Milestones Fueling Growth
TelyRx recently celebrated filling over one million prescriptions since its launch. This achievement showcases the company's operational capabilities and its expanding presence in the healthcare sector. Additionally, TelyRx will present at the Global Technology Virtual Investor Conference on July 9th, which is expected to draw more investor interest.
Market Performance and Future Outlook
The stock's 5.60% increase reflects positive market sentiment towards TelyRx, especially as it continues to grow its services across the U.S. However, potential investors should consider the company's current profit margin challenges alongside its growth prospects. With a market cap of CA$66.4 million, TelyRx is at a crucial point where strategic decisions will shape its future.
Advertisement
